Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...

AT-108 induces powerful, personalized anti-cancer responses by forcing tumor cells to present their antigens to the immune ...

Scientists reprogram brain cells to remove Alzheimer’s plaques with a single injection, showing a new approach to long-term ...

A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...

Cancer incidence rises sharply with age, yet the biological mechanisms that make older patients more vulnerable to treatment failure remain poorly ...

The stiffness of tumor tissue plays a role in how cancer spreads. Furthermore, stiff tumor tissue leaves traces in the ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...

Asgard Therapeutics will present new preclinical data on its lead asset AT‑108 in an oral presentation at the ASGCT Annual ...

Stem cell research holds enormous potential for treating disease, but it also raises deep ethical questions—especially when human embryos are involved. Recent debates have reignited calls to shift ...

Scientists from Trinity College Dublin and RCSI University of Medicine and Health Sciences have created new "hybrid" immune ...

Once in a blue moon, an animal cloning story appears in the headlines before disappearing back into the ether. Cloning is one ...